CCSD code A7300 – Peripheral nerve permanent lesion

Key Takeaways

A7300 covers three modalities: conventional radiofrequency, pulsed radiofrequency, and cryoprobe or phenol neurolysis of a named peripheral nerve.

The procedure note must identify the nerve by anatomical name – an unnamed nerve reference is a leading denial trigger.

Image guidance is optional under A7300 but must be documented in the operative record if claimed; fund rules on separate billing vary.

Pabau lets Australian pain practices attach CCSD codes, link image guidance documentation, and submit to private health funds from one clinical record.

CCSD code A7300: definition and clinical scope

CCSD code A7300 covers a procedure in which a named peripheral nerve is permanently lesioned using one of three modalities: radiofrequency energy (conventional thermal or pulsed), a cryoprobe, or injection of phenol. The official descriptor reads: Radiofrequency (including pulsed denervation), cryoprobe or phenol for permanent lesion of named peripheral nerve +/- image guidance.

The “+/-” wording on image guidance means the procedure qualifies for A7300 whether or not radiological guidance is used. However, if guidance is used, it must be documented. The code is maintained under the CCSD schedule, and individual private health funds apply their own benefit rules and fee schedules on top of the descriptor.

Three elements make A7300 distinct from neighbouring nerve procedure codes: the permanency of the intended lesion, the requirement for a named nerve, and the grouping of three mechanistically different modalities under one descriptor. Each element has a direct documentation implication.

Which modalities does A7300 cover?

A7300 groups three distinct procedural approaches. Their mechanisms differ, and so does the expected duration of nerve disruption – a fact some private health funds use when assessing repeat claims.

An important clinical and billing distinction: pulsed radiofrequency does not generate sufficient heat to destroy nerve tissue in the same way as conventional thermal RF. Some Australian private health funds treat pulsed RF differently from conventional RF for benefit purposes. Verify current fund-specific policy before submitting and document the modality explicitly by name.

What qualifies as a named peripheral nerve?

The descriptor’s phrase “named peripheral nerve” is a hard requirement. A procedure note that refers only to “the painful area,” “periarticular nerve,” or “nerve branches” will not satisfy the descriptor. The nerve must be identified by its anatomical name.

The following nerve groups are commonly targeted under A7300 in Australian interventional pain practice:

• Medial branch nerves (L1-L5, C3-C7) for facetogenic pain – document the specific spinal level and branch (e.g. “right L3 and L4 medial branch nerves”)
• Greater and lesser occipital nerves for occipital neuralgia
• Lateral femoral cutaneous nerve for meralgia paraesthetica
• Intercostal nerves (specify dermatome level) for post-thoracotomy or rib-related neuropathic pain
• Ilioinguinal and iliohypogastric nerves for post-surgical groin pain
• Genitofemoral nerve for chronic groin or scrotal pain
• Suprascapular nerve for refractory shoulder pain
• Infraorbital or mental nerve for trigeminal distribution facial pain

Medial branch nerves are the most frequently documented under A7300 for facetogenic pain. Verify whether a specific fund’s schedule uses a separate CCSD code for facet joint procedures – potential code confusion here is a genuine audit risk, and some funds crosswalk medial branch RF to a facet joint code rather than A7300.

Documentation requirements for A7300 claims

A complete operative or procedure note is the single most important piece of supporting documentation for an A7300 claim. The note must contain all of the following elements for the claim to survive audit.

Storing structured procedure notes within the patient’s clinical records alongside the CCSD code ensures that the documentation is retrievable if a fund requests supporting evidence. Using digital forms to capture procedure-specific fields at the point of care reduces the risk of retrospective documentation gaps.

Image guidance under A7300: billing and documentation

The “+/-” in the descriptor confirms image guidance is optional – A7300 applies whether or not guidance is used. What it does not resolve is whether image guidance attracts a separate billable code on top of A7300.

The answer depends on the individual fund. Some private health funds bundle image guidance within the A7300 fee; others recognise a separate radiological guidance code. Do not assume either position without checking the fund’s current schedule or clinical criteria document. Claiming a separate guidance code without fund recognition creates an overpayment risk and a potential audit finding.

• Document the guidance modality: record whether fluoroscopy, ultrasound, or CT guidance was used, and retain the imaging log or saved images
• Check fund rules before billing: some funds require image guidance for A7300 to be authorised (a pre-procedure requirement, not a billing addition); others treat it as an optional add-on
• Radiologist involvement: if a radiologist provides guidance separately, confirm whether that attracts a distinct CCSD code under their own billing rather than the proceduralist’s
• Intraoperative screening logs: for fluoroscopy, maintain a radiation dose record as part of the procedure note

MBS crosswalk and neighbouring CCSD codes

Australian practitioners billing through Medicare also need to consider the Medicare Benefits Schedule (MBS), administered by the Australian Government Department of Health and Aged Care. MBS item numbers for peripheral nerve destruction procedures differ from CCSD codes in descriptor wording and sometimes in the procedural groupings they recognise.

Verify current MBS item numbers against the Bupa code search portal and the relevant MBS Online schedule at time of billing – item numbers and descriptors change with annual MBS reviews. Any specific MBS item numbers published here are illustrative and should not be used without current-schedule verification.

A7300 is also commonly confused with neighbouring CCSD codes. The table below maps the most frequent code-confusion scenarios.

For practices billing under Bupa, the Bupa CCSD procedure codes guide outlines how Bupa applies CCSD descriptors in their own fee and authorisation framework. Separate guidance on the Bupa procedure codes fee schedule explains how Bupa structures fees by chapter and code group.

Payer requirements and prior authorisation

Prior authorisation requirements for A7300 vary by fund and change with annual policy reviews. No universal rule applies. Some funds require written authorisation before the procedure, particularly for pulsed RF, which some funds assess as less established than conventional thermal RF.

General criteria that funds typically assess for medical necessity include:

• Evidence of failed conservative management (physiotherapy, medication, structured exercise over a minimum period)
• A positive diagnostic nerve block result for the target nerve (for medial branch and similar peripheral nerve procedures)
• Specialist referral or a pain medicine specialist conducting the procedure
• Documented diagnosis consistent with the nerve lesion planned (e.g. facetogenic pain for medial branch RF, occipital neuralgia for occipital nerve procedures)

Check the current clinical criteria documents for major funds. Healix and Vitality both publish online fee schedules that include CCSD-coded procedure fees; Bupa, NIB, HCF, and Medibank maintain their own clinical criteria documents. Prior authorisation must be obtained before the procedure – retrospective authorisation is typically not accepted.

Manage CCSD claims and procedure documentation in one place

Pabau lets Australian pain and interventional medicine practices attach CCSD codes to procedure records, capture image guidance documentation, and submit claims to private health funds without switching systems.

Book a demo

Common denial reasons for CCSD code A7300

Most A7300 denials trace to a small number of documentation and coding errors. The table below maps the most frequent denial triggers to specific fixes.

Billing CCSD code A7300 in practice management software

Entering A7300 correctly in practice management software requires more than selecting the code from a list. The procedure note, the CCSD code, any image guidance record, and the fund-specific claim must all align.

Pabau’s claims management software lets Australian interventional pain practices attach CCSD codes to procedure records, link supporting documentation, and route claims to private health funds. Within the same record, clinicians can complete the procedure note and billing in one workflow rather than switching between a clinical system and a billing platform.

• Select the code: enter A7300 from the CCSD code library within the patient’s encounter record
• Attach image guidance documentation: if guidance was used, link the imaging log or scanned record to the procedure item before submission
• Confirm the modality in the procedure note: the note linked to the claim should state the modality explicitly – some funds audit the documentation attached to the claim, not just the code
• Check fund requirements: use the fund’s clinical criteria document to confirm benefit recognition and any prior authorisation reference numbers before submitting
• Record the submission date: tracking submission dates against benefit period rules for repeat A7300 claims helps avoid frequency-limit denials

For practices using broader practice management software, integrating CCSD code entry with the clinical record reduces the risk of a claim being submitted with an incomplete or mismatched procedure note.

Conclusion

CCSD code A7300 covers a clinically specific procedure: permanent lesioning of a named peripheral nerve using radiofrequency, cryoprobe, or phenol. The named nerve requirement, the modality documentation, and the image guidance rules are where most denials originate. Getting the procedure note right before the claim is submitted is the most reliable denial prevention strategy available.

Pabau helps Australian pain practices manage CCSD billing from the clinical record outward – attaching codes, documentation, and fund-specific requirements in one workflow. To see how it handles interventional pain billing, book a demo.

Continue your research

Billing multiple CCSD codes in one encounter? Bupa procedure codes fee schedule explains how Bupa structures chapter fees and applies unbundling rules across multi-code submissions.

Need to look up related Bupa CCSD codes? Bupa CCSD procedure codes covers the full Bupa CCSD framework including code recognition and submission requirements.

Want to streamline clinical documentation for procedure notes? Digital forms let practices build structured procedure note templates that capture all required A7300 documentation fields at the point of care.

Frequently Asked Questions